INTERNATIONAL PATENT: NURIX THERAPEUTICS, INC. FILES APPLICATION FOR "BIFUNCTIONAL COMPOUNDS FOR DEGRADING AURORA KINASE VIA UBIQUITIN PROTEOSOME PATHWAY"

GENEVA, Jan. 27 -- NURIX THERAPEUTICS, INC. (1700 Owens Street, Suite 2054th FloorSan Francisco, CA 94158) filed a patent application (PCT/US2025/038145) for "BIFUNCTIONAL COMPOUNDS FOR DEGRADING AURORA KINASE VIA UBIQUITIN PROTEOSOME PATHWAY" on Jul 17, 2025. With publication no. WO/2026/020051, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MIHALIC, Jeffrey (C/o Nurix Therapeutics, Inc.1700 Owens Street, Suite 2054th FloorSan Francisco, CA 94158), WEGRZYNIAK, Eric (C/o Nurix Therapeutics, Inc.1700 Owens Street, Suite 2...